SECURITIES PURCHASE AGREEMENT
Exhibit
99.1
Execution Copy
SECURITIES PURCHASE AGREEMENT (the
“Agreement”),
dated as of March [●], 2019, by and among MoneyOnMobile,
Inc., a Texas corporation, with headquarters located at 000 Xxxxx
Xxxxx Xxxxxx, Xxxxx 0000, Xxxxxx, XX 00000 (the “Company”), and the investors
listed on the Schedule of Buyers attached hereto (individually, a
“Buyer” and
collectively, the “Buyers”).
WHEREAS:
A. The
Company and each Buyer is executing and delivering this Agreement
in reliance upon the exemption from the registration requirements
of the Securities Act of 1933, as amended (the “Securities Act”), provided by
Regulations S, Regulation D or Section 4(a)(2)
thereunder.
B. The
Company has authorized the issuance of senior notes of the Company,
in substantially the form attached hereto as Exhibit A (the
“Notes”), in an
aggregate principal amount of Notes of up to $1,200,000, and
Warrants, in substantially the form attached hereto as Exhibit B (the
“Warrants”),
representing the right to purchase up to an aggregate of 55,600,000
shares of Common Stock (as defined below) (the shares of Common
Stock issuable upon exercise of the Warrants, collectively, the
“Warrant
Shares”).
C. Each
Buyer wishes to purchase, and the Company wishes to sell, at the
First Closing or any Subsequent Closing (each as defined below),
upon the terms and conditions stated in this Agreement, (i) that
aggregate principal amount of Notes set forth opposite such
Buyer’s name in column (3) on the Schedule of Buyers attached
hereto (which Notes issued to all Buyers at the Closing shall be no
greater than $1,200,000 aggregate principal amount), and (ii)
Warrants representing the right to purchase that number of shares
of Common Stock set forth opposite such Buyer’s name in
column (4) on the Schedule of Buyers (which Warrants issued to all
Buyers shall be exercisable for an aggregate maximum of 55,600,000
Warrant Shares).
D. The
Notes will rank senior to all outstanding and future indebtedness
of the Company and its Subsidiaries (as defined
below).
E. The
Notes, the Warrants and the Warrant Shares collectively are
referred to herein as the “Securities”.
AGREEMENT
NOW, THEREFORE, in consideration of the
premises and the mutual covenants contained herein and for other
good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and each Buyer hereby
agree as follows:
1. PURCHASE AND SALE OF NOTES AND
WARRANTS.
(a) Purchase of Notes and Warrants at
Closing. Subject to the satisfaction (or waiver) of the
conditions set forth in Sections 6 and 7 below, at the Closing,
the Company shall issue and sell to each Buyer, and each Buyer
severally, but not jointly, shall purchase from the Company, (x) a
Note in the original principal amount as is set forth opposite such
Buyer’s name in column (3) on the Schedule of Buyers (which
aggregate principal amount of Notes for all Buyers shall be no
greater than $1,200,000) and (y) Warrants to acquire up to that
number of Warrant Shares as is set forth opposite such
Buyer’s name in column (4) on the Schedule of Buyers (which
Warrants for all Buyers shall be exercisable for an aggregate
maximum of 55,600,000 Warrant Shares).
(b) Closing. The date and time of
the first closing of the purchase and sale of the Notes and the
Warrants pursuant to Section 1(a) (the
“First Closing”) shall be 10:00 a.m., New
York City time, on the second business day after the date of this
Agreement (or such other date and time as is mutually agreed to by
the Company and each Buyer), subject to the satisfaction of the
conditions set forth herein. The First Closing shall be held at the
offices of Norton Xxxx Xxxxxxxxx US LLP, 0000 Xxxxxx xx xxx
Xxxxxxxx, Xxx Xxxx, XX 00000. The Company may continue to offer and
sell Securities and conduct additional closings (each, a
“Subsequent Closing”) for the sale of such Securities
after the First Closing and until the termination of the Offering.
Unless earlier terminated, this Offering will continue until the
30th day
after the Closing Date of the First Closing. There may be more than
one Subsequent Closing; provided, however, that the final
Subsequent Closing shall take place no later than the
30th day
after the Closing Date of the First Closing. Notwithstanding the
foregoing, no more than $1,200,000 in principal amount of Notes and
Warrants to purchase no more than 55,600,000 Warrant Shares will be
sold at the First Closing and all Subsequent Closings. As used in
this Agreement, the term “Closing Date” shall mean such date
on which the First Closing or any Subsequent Closing, respectively,
actually occurs, unless otherwise specified or the context
otherwise requires. In addition, as used in this Agreement, the
term “Closing”
shall have the respective meaning of the First Closing or any
Subsequent Closing, as applicable.
1
(c) Purchase Price. The aggregate
purchase price for the Notes and the Warrants to be purchased by
each Buyer at the Closing shall be the amount set forth opposite
each Buyer’s name in column (5) of the Schedule of Buyers.
Each Buyer shall pay $1,000 for each $1,000 of principal amount of
Notes and related Warrants to be purchased by such Buyer at the
Closing. The Buyers and the Company agree that the Notes and the
Warrants constitute an “investment unit” for purposes
of Section 1273(c)(2) of the Internal Revenue Code of 1986, as
amended (the “Code”). The Buyers and the Company
mutually agree that the allocation of the issue price of such
investment unit between the Notes and the Warrants in accordance
with Section 1273(c)(2) of the Code and Treasury Regulation
Section 1.1273-2(h) shall be an aggregate amount allocated to
the Warrants as agreed among the Buyers and the Company and the
balance of the purchase price allocated to the Notes, and neither
the Buyers nor the Company shall take any position inconsistent
with such allocation in any tax return or in any judicial or
administrative proceeding in respect of taxes. The Buyers and the
Company mutually agree that of the aggregate proceeds from the sale
of the Securities to the Buyers shall be used as set forth on
Schedule 4(c) and of the aggregate
proceeds from the sale of the Securities at the First Closing, (i)
$400,000 shall be sent to the Company’s deposit account, and
(ii) $600,000 shall be advanced to the Company upon request from
time to time within five months after the Closing, subject to the
conditions set forth in the Note, including approval of the
requested amounts and proposed use thereof by the Board of
Directors of the Company. To the extent Securities are sold at any
Subsequent Closing, the Buyers participating in such Subsequent
Closing shall advance the full principal amount of the Notes sold
at such Subsequent Closing to the Company on the date of such
Subsequent Closing.
(d) Form of Payment. On the Closing
Date, (i) each Buyer shall pay its applicable purchase price to the
Company for the Notes and the Warrants to be issued and sold to
such Buyer at the Closing, by wire transfer of immediately
available funds in accordance with the Company’s written wire
instructions and (ii) the Company shall deliver to each Buyer the
Notes (allocated in the principal amounts as such Buyer shall
request) which such Buyer is then purchasing hereunder along with
the Warrants (allocated in the amounts as such Buyer shall request)
which such Buyer is purchasing hereunder, in each case duly
executed on behalf of the Company and registered in the name of
such Buyer or its designee.
2. BUYER’S REPRESENTATIONS AND
WARRANTIES. Each Buyer, severally and not jointly,
represents and warrants with respect to only itself that, as of the
date hereof and as of the Closing Date:
(a) Organization; Authority. Such
Buyer is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization
with the requisite power and authority to enter into and to
consummate the transactions contemplated by the Transaction
Documents (as defined below) to which it is a party and otherwise
to carry out its obligations hereunder and thereunder.
Non-U.S.-Person Buyers:
(i) Such Buyer is not a
U.S. Person (as defined in Rule 902 of Regulation S promulgated
under the Securities Act) and is not acquiring the Securities for
the account or benefit of any U.S. Person.
(ii) Such
Buyer is acquiring the Notes and Warrants from the Company and will
acquire Warrant Shares issuable upon exercise of the Warrants for
its own account, for investment purposes only and not with a view
to the resale and distribution thereof, in whole or in
part.
(iii) Such
Buyer acknowledges and agrees that hedging transactions involving
the Notes and Warrants or the Warrant Shares may not be conducted
unless conducted in compliance with law.
(iv) Such
Buyer acknowledges and agrees that, pursuant to the provisions of
Regulation S, the Securities cannot be sold, assigned, transferred,
conveyed, pledged or otherwise disposed of to any U.S. Person or
within the United States of America or its territories or
possessions for a period of six months from and after the Closing
Date, unless such securities are registered for sale in the United
States pursuant to an effective registration statement under the
Securities Act or another exemption from such registration is
available.
(v) Such Buyer
acknowledges that the Securities may only be sold offshore in
compliance with Regulation S or pursuant to an effective
registration statement under the Securities Act or another
exemption from such registration, if available. In connection with
any resale of the Securities pursuant to Regulation S, the Company
will not register a transfer not made in accordance with Regulation
S, pursuant to an effective registration statement under the
Securities Act or in accordance with another exemption from the
Securities Act.
(vi) Such
Buyer has not acquired the Securities as a result of, and will not
itself engage in, any “directed selling efforts” (as
defined in Regulation S under the Securities Act) in the United
States in respect of the Securities which would include any
activities undertaken for the purpose of, or that could reasonably
be expected to have the effect of, conditioning the market in the
United States for the resale of the Securities; provided, however, that the Buyer may
sell or otherwise dispose of the Securities pursuant to
registration thereof under the Securities Act and any applicable
state and provincial securities laws or under an exemption from
such registration requirements.
2
U.S.-Person Buyers:
(viii) Such
Buyer is acquiring the Securities solely for such Buyer’s own
account for investment purposes only and not with a view to or
intent of resale or distribution thereof, in whole or in part. Such
Buyer has no agreement or arrangement, formal or informal, with any
person to sell or transfer all or any part of the Securities and
has no plans to enter into any such agreement or
arrangement.
(ix) Such
Buyer is aware that an investment in the Securities is high risk,
involving a number of very significant risks.
(x) Such
Buyer is able to bear the economic risk of such Buyer’s
entire investment in the Securities and Buyer understands that the
Securities cannot be readily sold, and Buyer has adequate means of
providing for Buyer's current financial needs and possible personal
contingencies without having to resort to the funds contemplated to
be used for the purchase of the Securities.
(xi) Such
Buyer is an "accredited investor" as defined in SEC Rule 501(a)
under Regulation D as follows:
___________
(INITIAL if
applicable) Buyer’s net worth, or joint net worth with that
person’s spouse, at the time of his purchase exceeds
$1,000,000 excluding the person’s primary residence. Any
indebtedness that is secured by the person’s primary
residence, up to the estimated fair market value of the primary
residence at the time of the date of Subscription Agreement, shall
not be included as a liability. Indebtedness that is secured by the
primary residence in excess of the estimated fair market value of
the primary residence at the date of the Subscription Agreement
must be included as a liability,
___________
(INITIAL if
applicable) Buyer has an income in excess of $200,000 in each of
the two most recent years or joint income with that person’s
spouse in excess of $300,000 in each of those years and has a
reasonable expectation of reaching the same income level in the
current year,
___________
(INITIAL if
applicable) Buyer is a corporation, partnership or other entity,
not formed for the specific purpose of acquiring the Common Stock,
with total assets in excess of $5,000,000,
___________
(INITIAL if
applicable) Buyer is an entity in which all of the equity owners
are accredited investors;
and
such Buyer acknowledges that the Company may need to verify an
investor’s status as an “accredited investor” by
obtaining certain tax and financial information and documentation.
Such Buyer agrees to provide such information and documentation
which may include filed Form 1040 (“U.S. Individual Income
Tax Return”) for the two most recent tax years; Form W-2
(“Wage and Tax Statement”); and Form 1099 report of
various types of income. To verify eligibility based on net worth,
such information and documentation may include bank statements,
brokerage statements, tax assessments and appraisal reports. In
lieu of obtaining the foregoing income and net worth information
and documentation, we may obtain written confirmation from an
investor’s attorney, CPA, registered stock broker, investment
adviser that such person or entity has taken reasonable steps to
verify that the prospective investor is an “accredited
investor” within the prior three (3) months and has
determined that such purchaser is an “accredited
investor”.
(c) Reliance on Exemptions. Such
Buyer understands that the Securities are being offered and sold to
it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and
that the Company is relying in part upon the truth and accuracy of,
and such Buyer’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of such
Buyer set forth herein in order to determine the availability of
such exemptions and the eligibility of such Buyer to acquire the
Securities.
(d) Information. Such Buyer and its
advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and
materials relating to the offer and sale of the Securities that
have been requested by such Buyer. Such Buyer and its advisors, if
any, have been afforded the opportunity to ask questions of the
Company. Neither such inquiries nor any other due diligence
investigations conducted by such Buyer or its advisors, if any, or
its representatives shall modify, amend or affect such
Buyer’s right to rely on the Company’s representations
and warranties contained herein. Such Buyer understands that its
investment in the Securities involves a high degree of risk. Such
Buyer has sought such accounting, legal and tax advice as it has
considered necessary to make an informed investment decision with
respect to its acquisition of the Securities.
(e) No Governmental Review. Such
Buyer understands that no United States federal or state agency or
any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness
or suitability of the investment in the Securities nor have such
authorities passed upon or endorsed the merits of the offering of
the Securities.
3
(f) Transfer or Resale. Such Buyer
understands that: (i) the Securities have not been and are not
being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or
transferred unless (A) subsequently registered thereunder, (B) such
Buyer shall have delivered to the Company an opinion of counsel, in
a form reasonably acceptable to the Company, to the effect that
such Securities to be sold, assigned or transferred may be sold,
assigned or transferred pursuant to an exemption from such
registration, or (C) such Buyer provides the Company with
reasonable assurance that such Securities can be sold, assigned or
transferred pursuant to Rule 144 or Rule 144A promulgated under the
Securities Act (or a successor rule thereto) (collectively,
“Rule 144”);
(ii) any sale of the Securities made in reliance on Rule 144 may be
made only in accordance with the terms of Rule 144 and further, if
Rule 144 is not applicable, any resale of the Securities under
circumstances in which the seller (or the Person) through whom the
sale is made) may be deemed to be an underwriter (as that term is
defined in the Securities Act) may require compliance with some
other exemption under the Securities Act or the rules and
regulations of the United States Securities and Exchange Commission
(the “SEC”)
promulgated thereunder; and (iii) neither the Company nor any other
Person (as defined below) is under any obligation to register the
Securities under the Securities Act or any state securities laws or
to comply with the terms and conditions of any exemption
thereunder.
(g) Legends. Such Buyer understands
that the certificates or other instruments representing the Notes
and the Warrants and the stock certificates representing the
Warrant Shares, except as set forth below, shall bear any legend as
required by the “blue sky” laws of any state and a
restrictive legend in substantially the following form (and a
stop-transfer order may be placed against transfer of such stock
certificates):
[NEITHER THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE
NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE
BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN]
REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS.
THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED OTHER THAN (1) TO THE COMPANY, (2) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, AND IN
ACCORDANCE WITH ANY APPLICABLE LAWS OF ANY STATE OF THE UNITED
STATES, (3) IN AN OFFSHORE TRANSACTION COMPLYING WITH REGULATION S
UNDER THE SECURITIES ACT, (4) PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144, IF
APPLICABLE, UNDER THE SECURITIES ACT OR (5) IN A TRANSACTION THAT
DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT BUT IS IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AND IN RELATION TO
WHICH THE HOLDER HAS FURNISHED TO THE COMPANY AN OPINION TO SUCH
EFFECT FROM COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE
SATISFACTORY TO THE COMPANY PRIOR TO SUCH OFFER, SALE, TRANSFER OR
ASSIGNMENT.
Following
a request by a Buyer, the legend set forth above shall be removed
and the Company shall issue a certificate without such legend to
the holder of the Securities upon which it is stamped or issue to
such holder by electronic delivery at the applicable balance
account at The Depository Trust Company (“DTC”), if, unless otherwise
required by state securities laws, (i) such Securities are
registered for resale under the Securities Act, (ii) in connection
with a sale, assignment or other transfer, such holder provides the
Company with an opinion of counsel, in a generally acceptable form,
to the effect that such sale, assignment or transfer of the
Securities may be made without registration under the applicable
requirements of the Securities Act, or (iii) the Securities can be
sold, assigned or transferred pursuant to Rule 144 or Rule 144A
without the need for current public information. The Company shall
be responsible for the fees of its transfer agent and all DTC fees
associated with such issuance.
(h) Validity; Enforcement. This
Agreement has been duly and validly authorized, executed and
delivered on behalf of such Buyer and shall constitute the legal,
valid and binding obligations of such Buyer enforceable against
such Buyer in accordance with their respective terms, except as
such enforceability may be limited by general principles of equity
or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or
affecting generally, the enforcement of applicable creditors’
rights and remedies.
(i) No Conflicts. The execution,
delivery and performance by such Buyer of this Agreement and the
consummation by such Buyer of the transactions contemplated hereby
will not (i) result in a violation of the organizational documents
of such Buyer, (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which such Buyer is a party, or (iii)
result in a violation of any law, rule, regulation, order, judgment
or decree (including federal and state securities laws) applicable
to such Buyer, except in the case of clauses (ii) and (iii) above,
for such conflicts, defaults, rights or violations which would not,
individually or in the aggregate, reasonably be expected to have a
material adverse effect on the ability of such Buyer to perform its
obligations hereunder.
4
3. REPRESENTATIONS AND WARRANTIES OF THE
COMPANY.
The
Company represents and warrants to each of the Buyers that, as of
the date hereof and as of the Closing Date:
(a) Organization. The Company and
each of its Subsidiaries (as defined below) is a company duly
organized and validly existing under the laws of the jurisdiction
in which it is organized and has the requisite corporate power and
authority to carry on its business as it is now being conducted.
The Company and each of its Subsidiaries is in good standing under
the laws of the jurisdiction in which it is organized.
(b) Due Authorization;
Enforceability. The Company has all right, corporate power
and authority to enter into, execute and deliver, and to perform
its obligations under, this Agreement, the Notes, the Warrants, the
Subordination and Standstill Agreement by and among the Company, S7
Finance B.V., as agent for the Buyers, and certain creditors of the
Company (the “Subordination
and Standstill Agreement”), the Security Agreement by
and between the Company and S7 Finance B.V., as agent for the
Buyers (the “Security
Agreement”), and each of the other agreements entered
into by the parties hereto in connection with the transactions
contemplated by this Agreement (collectively, the
“Transaction
Documents”) and to issue the Securities in accordance
with the terms hereof and thereof. The execution and delivery of
the Transaction Documents by the Company and the compliance by the
Company with each of the provisions of the Transaction Documents
(including the issuance of the Notes and the Warrants, and the
reservation for issuance and issuance of Warrant Shares issuable
upon exercise of the Warrants) are within the corporate power and
authority of the Company and have been duly authorized by all
requisite corporate and other action of the Company. This Agreement
has been, and the other Transaction Documents to which it is a
party will be prior to the Closing, duly and validly executed and
delivered by the Company, and each constitutes, or when executed
will constitute, a legal, valid and binding agreement of the
Company, enforceable against the Company in accordance with their
respective terms, except as such enforcement is limited by
bankruptcy, insolvency and other similar laws affecting the
enforcement of creditors’ rights generally and for limitation
imposed by general principles of equity, regardless of whether
enforcement is sought at law or in equity and insofar as
indemnification and contribution provisions may be limited by
applicable law.
(c) Subsidiaries. The Company has
no Subsidiaries except as set forth on the disclosure letter
furnished to Buyers, which sets forth an organizational chart
depicting each Subsidiary of the Company (and any Subsidiary of
each Subsidiary of the Company), and the number and percentage of
shares of outstanding capital stock or other equity or similar
interest held by the Company or applicable Subsidiary.
“Subsidiaries”
means any Person (as defined below) in which the Company, directly
or indirectly, (x) owns any of the outstanding capital stock or
holds any equity or similar interest of such Person or (y) controls
or operates all or any part of the business, operations or
administration of such Person, and each of the foregoing, is
individually referred to herein as a “Subsidiary”; provided, however, that for purposes of
the representations and warranties of the Company in this Agreement
the term “Subsidiary” shall expressly not include My
Mobile Payments Ltd. (“MMPL”). For the avoidance of
uncertainty, notwithstanding anything else to the contrary herein,
the Company is UNABLE TO
REPRESENT and DOES NOT MAKE ANY
REPRESENTATIONS HEREIN regarding My Mobile Payments Ltd. due to the
pending dispute in India. “Person” means an individual or
corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock
company, government (or an agency or subdivision thereof) or other
entity of any kind.
(d) SEC Reports. The Company is
UNABLE TO
REPRESENT and DOES NOT
REPRESENT that it has filed all reports, schedules, forms,
statements and other documents required to be filed by the Company
under the Securities Act and the Securities Exchange Act of 1934,
as amended, and the rules and regulations promulgated thereunder
(the “Exchange
Act”), including pursuant to Section 13(a) or 15(d)
thereof, for the two years preceding the date hereof (or such
shorter period as the Company was required by law or regulation to
file such material) (the foregoing materials, including the
exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Reports”). THE COMPANY IS
DELINQUENT IN ITS FILING OBLIGATIONS UNDER THE EXCHANGE
ACT.
(e) Issuance of Securities. The
issuance of the Notes and the Warrants are duly authorized and,
upon issuance, shall be validly issued and free from all taxes,
liens and charges with respect to the issue thereof. As of the
Closing, a number of shares of Common Stock shall have been duly
authorized and reserved for issuance which equals or exceeds (the
“Required Reserved
Amount”) 100% of the maximum number of Warrant Shares
issued and issuable pursuant to the Warrants, each as of the
Trading Day (as defined in the Warrants) immediately preceding the
applicable date of determination. Upon exercise of the Warrants in
accordance with the Warrants, the Warrant Shares, when issued, will
be validly issued, fully paid and nonassessable and free from all
preemptive or similar rights, taxes, liens and charges with respect
to the issue thereof, with the holders being entitled to all rights
accorded to a holder of Common Stock. Subject to the accuracy of
each of the representations and warranties of the Buyers set forth
in Section 2 of this Agreement, the
offer and issuance by the Company of the Securities is exempt from
registration under the Securities Act. “Common Stock” means (i) the
Company’s shares of Common Stock, par value $0.001 per share,
and (ii) any capital stock into which such common stock shall have
been changed or any share capital resulting from a reclassification
of such common stock.
5
(f) No Conflicts or Violation; Consents
and Approvals. Neither the execution, delivery or
performance by the Company of this Agreement or the Transaction
Documents, nor the consummation of the transactions contemplated
hereby and thereby (including the issuance of the Notes and the
Warrants, and the reservation for issuance and issuance of Warrant
Shares issuable upon exercise of the Warrants) will:
(i) conflict with, or
result in a breach or a violation of, any provision of the
organizational documents of the Company or (ii) constitute a
breach, violation or default, or give rise to any right of
termination, modification, cancellation, prepayment, suspension,
limitation, revocation or acceleration, under any (1) law
applicable to or binding on the Company or (2) provision of any
commitment to which the Company is a party, except in the case of
clause (a)(ii)(1), such conflict, breach, violation or default
would not result in a Material Adverse Change. “Material
Adverse Change” means any material adverse change on the
business, properties, assets, liabilities, operations (including
results thereof), condition (financial or otherwise) or prospects
of the Company and its subsidiaries, taken as a whole;
and
(ii) require
the Company to make or obtain the consent, waiver, agreement,
approval, permit or authorization of, or declaration, filing,
notice or registration to or with, or assignment by, any
governmental entity or any Person that is not a governmental entity
(including any party to any commitment to which the Company is a
party to), except in the case of clause (b), where the failure to
obtain consent would not result in a Material Adverse
Change.
(g) Application of Takeover Protections;
Rights Agreement. The Company and its board of directors
have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Certificate of
Formation or the laws of the State of Texas which is or could
become applicable to any Buyer as a result of the transactions
contemplated by this Agreement, including the Company’s
issuance of the Securities and any Buyer’s ownership of the
Securities. The Company has not adopted a stockholder rights plan
or similar arrangement relating to accumulations of beneficial
ownership of Common Stock or a change in control of the
Company.
(h) Transactions With Affiliates and
Employees.
(i) None of the
officers or directors of the Company and, to the knowledge of the
Company, none of the employees of the Company is presently a party
to any transaction with the Company or its subsidiary (other than
for services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or
personal property to or from, providing for the borrowing of money
from or lending of money to or otherwise requiring payments to or
from any officer, director or such employee or, to the knowledge of
the Company, any entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director,
trustee or partner, in each case in excess of $25,000 other than
for: (i) payment of salary or consulting fees for services
rendered, (ii) reimbursement for expenses incurred on behalf of the
Company and (iii) other employee benefits, including stock option,
restricted stock or other compensation-related agreements under any
equity plan of the Company.
(ii) The
Company has furnished to the Buyers a disclosure letter which
contains true and correct information regarding (a) the total
number of employees and consultants employed or engaged by the
Company and its Subsidiaries as of January 31, 2019 and (b) the
aggregate annual compensation of such employees and
consultants.
(i) Equity
Capitalization. The Company has furnished to the Buyers a
disclosure letter which contains true and correct information
regarding (i) the number of authorized and outstanding shares of
capital stock of the Company; (ii) any preemptive rights or other
similar rights or any liens or encumbrances suffered or permitted
by the Company with respect to such shares of capital stock; (iii)
any outstanding options, warrants, scrip, rights to subscribe to,
calls or commitments of any character whatsoever relating to, or
securities or rights convertible into, or exercisable or
exchangeable for, any shares of capital stock of the Company or any
of its Subsidiaries, or contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or
may become bound to issue additional shares of capital stock of the
Company or any of its Subsidiaries or options, warrants, scrip,
rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into,
or exercisable or exchangeable for, any shares of capital stock of
the Company or any of its Subsidiaries other than equity awards
(including to employees and directors); (iv) any financing
statements securing obligations in any material amounts, either
singly or in the aggregate, filed in connection with the Company or
any of its Subsidiaries; (v) any agreements or arrangements under
which the Company or any of its Subsidiaries is obligated to
register the sale of any of their securities under the Securities
Act; (vi) any outstanding securities or instruments of the Company
or any of its Subsidiaries which contain any redemption or similar
provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is
or may become bound to redeem a security of the Company or any of
its Subsidiaries; (vii) any securities or instruments
containing anti-dilution or similar provisions that will be
triggered by the issuance of the Securities; and (viii) any stock
appreciation rights or “phantom stock” plans or
agreements or any similar plan or agreement. All of such
information in the disclosure letter remains true and correct as of
the date hereof. The Company has furnished or made available to the
Buyers true, correct and complete copies of the Company’s
Certificate of Formation, as amended and as in effect on the date
hereof, including the Certificates of Designation thereto (the
“Certificate of
Formation”), and the Company’s Bylaws, as
amended and as in effect on the date hereof (the
“Bylaws”), and
the terms of all securities convertible into, or exercisable or
exchangeable for shares of Common Stock and the material rights of
the holders thereof in respect thereto.
6
(j) Indebtedness and Other
Contracts.
(i) The Company has
furnished to the Buyers a disclosure letter which contains true and
correct information regarding (i) any outstanding Indebtedness (as
defined below) of the Company and its Subsidiaries as of January
31, 2019, (ii) any outstanding trade payables of the Company and
its Subsidiaries as of January 31, 2019, (iii) any contract,
agreement or instrument to which the Company or any of its
Subsidiaries is a party, the violation of which, or default under
which, by the other party(ies) to such contract, agreement or
instrument could reasonably be expected to result in a Material
Adverse Effect, (iv) any violation of any term of or in default
under any contract, agreement or instrument relating to any
Indebtedness of the Company and its Subsidiaries, except where such
violations and defaults would not result, individually or in the
aggregate, in a Material Adverse Effect, or (v) any contract,
agreement or instrument to which the Company or any of its
Subsidiaries is a party relating to any Indebtedness, the
performance of which, in the judgment of the Company’s
officers, has or is expected to have a Material Adverse Effect.
Such information includes a detailed description of the material
terms of any such outstanding Indebtedness of the Company and its
Subsidiaries and all of such information in the disclosure letter
remains true and correct as of the date hereof. For purposes of
this Agreement: (x) “Indebtedness” of any Person means,
without duplication (A) all indebtedness for borrowed money, (B)
all obligations issued, undertaken or assumed as the deferred
purchase price of property or services, including “capital
leases” in accordance with United States generally accepted
accounting principles (other than trade payables entered into in
the ordinary course of business consistent with past practice), (C)
all reimbursement or payment obligations with respect to letters of
credit, surety bonds and other similar instruments, (D) all
obligations evidenced by notes, bonds, debentures or similar
instruments, including obligations so evidenced incurred in
connection with the acquisition of property, assets or businesses,
(E) all indebtedness created or arising under any conditional sale
or other title retention agreement, or incurred as financing, in
either case with respect to any property or assets acquired with
the proceeds of such indebtedness (even though the rights and
remedies of the seller or bank under such agreement in the event of
default are limited to repossession or sale of such property), (F)
all monetary obligations under any leasing or similar arrangement
which, in connection with United States generally accepted
accounting principles, consistently applied for the periods covered
thereby, is classified as a capital lease, (G) all indebtedness
referred to in clauses (A) through (F) above secured by (or for
which the holder of such Indebtedness has an existing right,
contingent or otherwise, to be secured by) any mortgage, lien,
pledge, charge, security interest or other encumbrance upon or in
any property or assets (including accounts and contract rights)
owned by any Person, even though the Person which owns such assets
or property has not assumed or become liable for the payment of
such indebtedness, and (H) all Contingent Obligations in respect of
indebtedness or obligations of others of the kinds referred to in
clauses (A) through (G) above; and (y) “Contingent Obligation” means, as
to any Person, any direct or indirect liability, contingent or
otherwise, of that Person with respect to any Indebtedness, lease,
dividend or other obligation of another Person if the primary
purpose or intent of the Person incurring such liability, or the
primary effect thereof, is to provide assurance to the obligee of
such liability that such liability will be paid or discharged, or
that any agreements relating thereto will be complied with, or that
the holders of such liability will be protected (in whole or in
part) against loss with respect thereto.
(ii) The
Company has furnished to the Buyers a disclosure letter which
contains true and correct information regarding any agreement,
understanding, instrument, contract or proposed transaction to
which the Company is a party or by which it is bound that involves
the obligation of the Company or its stockholders, or the grant of
rights to any Person, to elect, appoint or designate a director of
the Company.
(k) Subsidiary Investments. The
Company has furnished to the Buyers a disclosure letter which
contains true and correct information regarding all investments in,
cash contributions or loans to, or amounts in excess of $25,000
paid or incurred for the benefit of, any Subsidiary of the Company
located or operating in India or the India business operations, in
each case in the past 24 months.
(l) Private Placement. Assuming the
accuracy of the Buyers’ representations and warranties set
forth in Section
2(b), no registration under
the Securities Act is required for the offer and sale of the
Securities by the Company to the Buyers as contemplated
hereby.
(m) Ranking of Notes. No
Indebtedness of the Company or any of its Subsidiaries is senior to
or ranks pari passu with
the Notes in right of payment, whether with respect of payment of
redemptions, interest, damages or upon liquidation or dissolution
or otherwise.
(n) No Payment of Transfer Taxes.
No transfer, documentary, stamp, sales, use and other taxes have
been or will be required or imposed by reason of, the transfer of
the Securities to the Buyers.
7
(o) Office of Foreign Assets
Control. Neither the Company or any of its Subsidiaries nor,
to the Company’s knowledge, any director, officer, agent,
employee or affiliate of the Company or any of its Subsidiaries is
currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department.
“Affiliate” means any Person that, directly or
indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such
terms are used in and construed under Rule 144 under the Securities
Act.
(p) Money Laundering. The Company
and its Subsidiaries are in compliance with, and have not
previously violated, the USA Patriot Act of 2001 and all other
applicable U.S. and non-U.S. anti-money laundering laws and
regulations, including, but not limited to, the laws, regulations
and Executive Orders and sanctions programs administered by the
U.S. Office of Foreign Assets Control, including, but not limited,
to (i) Executive Order 13224 of September 23, 2001 entitled,
“Blocking Property and Prohibiting Transactions With Persons
Who Commit, Threaten to Commit, or Support Terrorism” (66
Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31
CFR, Subtitle B, Chapter V.
4. COVENANTS AND OTHER
AGREEMENTS.
(a) Best Efforts. Each party shall
use its best efforts timely to satisfy each of the covenants and
the conditions to be satisfied by it as provided in Sections 6 and 7 of this
Agreement.
(b) Reporting Status. Until the
date on which the Buyers shall have sold all of the Warrant Shares
and none of the Notes or Warrants are outstanding (the
“Reporting
Period”), the Company shall use its reasonable efforts
to file all reports required to be filed with the SEC pursuant to
the 1934 Act, and without the written consent of the Required
Warrant Holders (as defined below) the Company shall not terminate
its status as an issuer required to file reports under the 1934
Act.
(c) Use of Proceeds. The Company
will use the proceeds from the sale of the Securities solely as set
forth on Schedule
4(c).
(d) Expenses. Except as otherwise
set forth in the Transaction Documents, each party to this
Agreement shall bear its own expenses in connection with the sale
of the Securities to the Buyers.
(e) Disclosure of Transactions and Other
Material Information. On or before 8:30 a.m., New York City
time, on the fourth Business Day after this Agreement has been
executed, the Company shall file one or more Current Reports on
Form 8-K describing the material terms of the transactions
contemplated by the Transaction Documents in the form required by
the 1934 Act and attaching the material Transaction Documents
(including this Agreement, the form of Note and the form of the
Warrant) as exhibits to such filing.
8
(f) Additional Notes. So long as
any Buyer beneficially owns any Notes, the Company will not issue
any Notes other than as contemplated hereby and the Company shall
not issue any other securities that would cause a breach or default
under the Notes.
(g) Corporate Existence. So long as
any Buyer beneficially owns any Securities, the Company shall (i)
maintain its corporate existence and (ii) not be party to any
Fundamental Transaction (as defined in the Notes) unless the
Company is in compliance with the applicable provisions governing
Fundamental Transactions set forth in the Notes and the
Warrants.
(h) Reservation of Shares. So long
as any Notes or Warrants remain outstanding, the Company shall take
all action necessary to at all times have authorized, and reserved
for the purpose of issuance, no less than the Required Reserved
Amount. If at any time the number of shares of Common Stock
authorized and reserved for issuance is not sufficient to meet the
Required Reserved Amount, the Company will promptly take all
corporate action necessary to authorize and reserve a sufficient
number of shares.
(i) Conduct of Business. The
business of the Company and its Subsidiaries shall not be conducted
in violation of any law, ordinance or regulation of any
governmental entity, except where such violations would not result,
either individually or in the aggregate, in a Material Adverse
Effect. For the avoidance of doubt, the Company’s existing
delinquency in filing SEC Reports shall not deemed to be such a
violation for purposes of this Agreement.
(j) Litigation. During the
Reporting Period, the Company and its Subsidiaries shall not shall
not threaten, commence, settle, compromise or offer to settle or
compromise any material claim, complaint, demand, grievance,
prosecution, action, appeal, petition, plea, charge, suit,
litigation, arbitration, mediation, hearing, inquiry, investigation
or similar legal, judicial, arbitral or administrative proceeding
involving the Company or any of its Subsidiaries or their
respective current or former management without the written consent
of the Required Note Holders.
(k) Piggyback Registration Rights.
If at any time the Company has registered or has determined to
register any of its securities for its own account or for the
account of other security holders of the Company on any
registration form (other than Form S-4 or S-8) which permits
the inclusion of the Warrant Shares (a “Piggyback Registration”), the
Company will give the Buyers written notice thereof promptly (but
in no event less than 15 days prior to the anticipated filing
date) and shall include in such registration all Warrant Shares
requested to be included therein pursuant to the written request of
one or more Buyers received within 10 days after delivery of
the Company’s notice. If a Piggyback Registration is
initiated as a primary underwritten offering on behalf of the
Company, and the managing underwriters advise the Company and the
Buyers that in their reasonable opinion the number of Warrant
Shares proposed to be included in such registration will jeopardize
the success of the subject offering (including the offering price
per share), the Company shall include in such registration:
(i) first, the number of shares of Common Stock that the
Company proposes to sell; and (ii) second, the number of
Warrant Shares requested to be included therein by the Buyers who
have provided notice in accordance with this Section 4(k) pro rata among all
such holders on the basis of the number of Warrant Shares requested
to be included therein by all such Buyers or as such Buyers and the
Company may otherwise agree. In addition, if requested in writing
by the Required Warrant Holders, the Company and the Buyers shall
enter into a registration rights agreement regarding the Warrant
Shares in substantially the form as the registration rights
agreement, dated as of April 28, 2011, between the Company and HD
Special-Situations II, LP. as filed as exhibit 4.1 to the
Company’s Form 8-K filed with the SEC on May 4,
2011.
(l) Stock Splits. Until the Notes
are no longer outstanding, the Company shall not effect any stock
combination, reverse stock split or other similar transaction (or
make any public announcement or disclosure with respect to any of
the foregoing) without the prior written consent of the Required
Note Holders.
(m) Closing Documents. On or prior
to fourteen (14) calendar days after the Closing Date, the Company
agrees to deliver, or cause to be delivered, to each Buyer executed
copies of the Transaction Documents, Securities and any other
documents required to be delivered to any party pursuant to
Section 7 hereof or
otherwise.
(n) Board of Directors and Board
Representation. The Company agrees that it will take all
reasonable action, effective at or promptly after the Closing, to
fix the size of its Board of Directors at five (5) members. The
Company agrees that it will not increase the size of its Board of
Directors beyond five (5) members for as long as the Notes are
outstanding without the consent of the Required Note Holders. S7
Finance B.V. shall have the right to appoint, and the Company shall
promptly (but no later than three (3) days following written
request from S7 Finance B.V.) appoint, three (3) members of the
Company’s Board of Directors; and the remaining two (2)
members shall be appointed by the Company’s stockholders. In
addition, for so long as any Notes are outstanding, the Required
Note Holders shall have the right to appoint one observer to
participate (in person or electronically) in each meeting of the
Company’s Board of Directors.
9
(o) Litigation Committee. Promptly
following closing, the Company’s board of directors shall
establish a special committee to review and supervise the conduct
of litigation matters (the “Special Litigation Committee”),
which Special Litigation Committee shall be comprised of up to
three (3) directors, of which a majority of the directors shall
consist of directors designated by S7 Finance B.V., if S7 Finance
B.V. shall have designated directors. The Company shall engage,
retain or issue a power of attorney to Xx. Xxxxxxx X
Xxxxxxxxxxxx of Argus Partners, Mumbai, India (or one or more other
representatives or consultants acceptable to S7 Finance B.V.)
(each, a “Litigation
Coordinator”) who shall be granted full authority and
be empowered, as permitted by law, to negotiate on behalf of the
Company in respect of the Company’s court, litigation,
arbitration, enforcement, mediation and/or settlement matters,
including the Company’s dispute with MMPL and its related
shareholders and companies. The Litigation Coordinator shall
participate in all discussions and negotiations (whether in person
or by telephone) involving such matters, including strategy
discussions and settlement negotiations, and shall be furnished
copies of all correspondence by and between the Company and counsel
of the Company regarding such litigation/dispute matters. The
Litigation Coordinator shall be subject to supervision by, and
shall report to, the Special Litigation Committee, and any final
settlement offers shall be subject to approval by the Special
Litigation Committee.
(p) Legal Counsel. The Company
shall take reasonable steps to hire an internal legal counsel (or
Senior Litigation Officer or equivalent), whose candidacy shall be
approved by the Company’s board of directors, and such person
will be responsible for providing reports to the Company’s
board of directors upon request, subject to the reasonable terms of
the engagement of such counsel.
(q) Amendment to Series H Preferred
Stock. The Company shall, within 10 days of the Closing,
have delivered to such Buyer an amendment or restatement of the
Certificates of Designation of Series H Preferred Stock held by S7
Finance B.V. to permit the holder to increase or decrease the 4.99%
ownership limitation applicable to its shares of Preferred Stock by
providing not less than 61 days’ prior written notice to the
Company.
(r) Sale of Additional Notes and
Additional Warrants. Within 30 days after the First Closing,
and subject to the final sentence of this paragraph, the Company
may sell additional Notes and Warrants on the same economic terms
as the Notes and Warrants sold to the Buyers at the First Closing
(including, for the avoidance of doubt, maturity date of the Notes,
and except that the amount of the loan represented by any such
additional Note shall be fully funded on the date of issuance of
such additional Note and the Buyer thereof shall have no ongoing
commitment to fund under such additional Note) and in accordance
with all applicable securities laws. Such sales of additional Notes
and Warrants shall not cause the amount of Securities to be sold at
all Closings to exceed $1,200,000 in aggregate principal amount of
Notes sold hereunder, and not to exceed Warrants representing the
right to purchase aggregate maximum of 55,600,000 Warrant
Shares.
(s) Authorization to File. The
Company and each Buyer hereby authorizes the Agent and/or its
counsel to file UCC financing statements without notice to the
Company, with all appropriate jurisdictions, as the Agent deems
appropriate, in order to further perfect or protect the
Agent’s interest in the Collateral (for the ratable benefit
of the Secured Parties (as defined in the Security Agreement)),
including a notice that any disposition of the Collateral, by
either the Company or any other Person, shall be deemed to violate
the rights of the Agent under the Uniform Commercial
Code.
5. REGISTER; TRANSFER AGENT
INSTRUCTIONS.
(a) Register. The Company shall
maintain at its principal executive offices (or such other office
or agency of the Company as it may designate by notice to each
holder of Securities), a register for the Notes and the Warrants in
which the Company shall record the name and address of the Person
in whose name the Notes and the Warrants have been issued
(including the name and address of each transferee), the principal
amount of Notes held by such Person, and the number of Warrant
Shares issuable upon exercise of the Warrants held by such Person.
The Company shall keep the register open and available at all times
during business hours for inspection of any Buyer or its legal
representatives.
(b) Transfer Agent Instructions.
The Company shall issue irrevocable instructions to its transfer
agent, and any subsequent transfer agent (the “Transfer Agent Instructions”) to
issue certificates or credit shares to the applicable balance
accounts at DTC, registered in the name of each Buyer or its
respective nominee(s), for the Warrant Shares upon exercise of the
Warrants in such amounts as specified from time to time by each
Buyer to the Company upon exercise of the Warrants. If a Buyer
effects a sale, assignment or transfer of the Securities in
accordance with Section 2(f), the Company shall
permit the transfer and shall promptly instruct its transfer agent
to issue one or more certificates or credit shares to the
applicable balance accounts at DTC in such name and in such
denominations as specified by such Buyer to effect such sale,
transfer or assignment. In the event that such sale, assignment or
transfer involves the Warrant Shares sold, assigned or transferred
pursuant to an effective registration statement or pursuant to Rule
144, the transfer agent shall issue such Securities to the Buyer,
assignee or transferee, as the case may be, without any restrictive
legend. The Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to a Buyer.
Accordingly, the Company acknowledges that the remedy at law for a
breach of its obligations under this Section 5(b) will be inadequate and
agrees, in the event of a breach or threatened breach by the
Company of the provisions of this Section 5(b), that a Buyer shall be
entitled, in addition to all other available remedies, to an order
and/or injunction restraining any breach and requiring immediate
issuance and transfer, without the necessity of showing economic
loss and without any bond or other security being required. The
Company shall cause its counsel to issue any requisite legal
opinion referred to in the Transfer Agent Instructions to the
Company’s transfer agent. Any fees (with respect to the
transfer agent, counsel to the Company or otherwise) associated
with the issuance of such opinion or the removal of any legends on
any of the Securities shall be borne by the Company.
10
The
obligation of the Company hereunder to issue and sell the Notes and
the related Warrants to each Buyer at the Closing is subject to the
satisfaction, at or before the Closing Date, of each of the
following conditions, provided that these conditions are for the
Company’s sole benefit and may be waived by the Company at
any time in its sole discretion by providing each Buyer with prior
written notice thereof:
(i) Such Buyer shall
have executed each of the Transaction Documents to which it is a
party and delivered the same to the Company.
(ii) Such
Buyer shall have delivered the purchase price contemplated by
Section 1(c) hereof for the Notes
and the related Warrants being purchased by such Buyer at the
Closing pursuant to Section 1(d) hereof by wire
transfer of immediately available funds pursuant to the wire
instructions provided by the Company.
(iii) The
representations and warranties of such Buyer shall be true and
correct as of the date when made and in all material respects
(except for such representation and warranties qualified by
material, which shall be true and correct in all respects) as of
the Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date
which shall be true and correct as of such specified date), and
such Buyer shall have performed, satisfied and complied in all
material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied
with by such Buyer at or prior to the Closing Date.
The
obligation of each Buyer hereunder to purchase the Notes and the
related Warrants at the Closing is subject to the satisfaction, at
or before the Closing Date, of each of the following conditions,
provided that these conditions are for each Buyer’s sole
benefit and may be waived by such Buyer at any time in its sole
discretion by providing the Company with prior written notice
thereof:
(i) The Company shall
have duly executed and delivered to such Buyer each of the
following documents to which it is a party: (A) each of the
Transaction Documents, (B) the Notes (allocated in such principal
amounts as such Buyer shall request), being purchased by such Buyer
at the Closing pursuant to this Agreement and (C) the related
Warrants (allocated in such amounts as such Buyer shall request)
being purchased by such Buyer at the Closing pursuant to this
Agreement.
(ii) The
Company shall have delivered to such Buyer a copy of the
Subordination and Standstill Agreement with certain creditors of
the Company for borrowed money (relating to forbearance of
principal and interest payments until the Notes shall have been
paid in full) in a form reasonably acceptable to such
Buyer.
(iii) The
Company shall have delivered to such Buyer a certificate evidencing
the formation and good standing of the Company in such
entity’s jurisdiction of formation issued by the Secretary of
State (or comparable office) of such jurisdiction, as of a date
within ten (10) days of the Closing Date.
(iv) The
Company shall have delivered to such Buyer a written consent or
certified resolutions consistent with Section 3(b) and Section 3(g) as adopted by the
Company’s Board of Directors in a form reasonably acceptable
to such Buyer.
(v) The representations
and warranties of the Company shall be true and correct as of the
date when made and in all material respects (except for such
representation and warranties qualified by material or Material
Adverse Effect, which shall be true and correct in all respects) as
of the Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date
which shall be true and correct as of such specified date) and the
Company shall have performed, satisfied and complied in all
respects with the covenants, agreements and conditions required by
the Transaction Documents to be performed, satisfied or complied
with by the Company at or prior to the Closing Date. Such Buyer
shall have received a certificate, executed by the Chief Executive
Officer and Chief Financial Offer of the Company, dated as of the
Closing Date, to the foregoing effect and as to such other matters
as may be reasonably requested by such Buyer.
(vi) The
Company shall have obtained all governmental, regulatory or third
party consents and approvals, if any, necessary for the sale of the
Securities.
(vii) No
statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or
endorsed by any court or other governmental entity of competent
jurisdiction that prohibits the consummation of any of the
transactions contemplated by the Transaction
Documents.
(viii) Such
Buyer shall have received a letter on the letterhead of the
Company, duly executed by the Chief Executive Officer of the
Company, setting forth the wire transfer instructions of the
Company.
(ix) The
Company shall have delivered to such Buyer such other documents
relating to the transactions contemplated by this Agreement as such
Buyer or its counsel may reasonably request.
11
8. TERMINATION. In the event that
the Closing shall not have occurred with respect to a Buyer on or
before five (5) Business Days from the date hereof due to the
Company’s or such Buyer’s failure to satisfy the
conditions set forth in Sections 6 and 7 above (and the
nonbreaching party’s failure to waive such unsatisfied
condition(s)), the nonbreaching party shall have the option to
terminate this Agreement with respect to such breaching party at
the close of business on such date by delivering a written notice
to that effect to each other party to this Agreement and without
liability of any party to any other party. Nothing contained in
this Section 8 shall be deemed to
release any party from any liability for any breach by such party
of the terms and provisions of this Agreement or the other
Transaction Documents or to impair the right of any party to compel
specific performance by any other party of its obligations under
this Agreement or the other Transaction Documents.
9. AGENT
(a) Appointments and Authority.
Each Buyer hereby irrevocably appoints S7 Finance B.V. to act on
its behalf as the collateral agent under the Security Agreement and
the senior agent under the Subordination and Standstill Agreement
(in such capacities, the “Agent”) and authorizes the Agent
to take such actions on its behalf and to exercise such powers as
are delegated to the Agent by the terms hereof or thereof,
including for purposes of acquiring, holding and enforcing any and
all Liens (as defined in the Notes) to secure any of the
Obligations (as defined in the Security Agreement) on Collateral
(as defined in the Security Agreement) granted by the Company to
secure any of the Obligations, together with such powers and
discretion as are reasonably incidental thereto. The provisions of
this Article are solely for the benefit of the Agent and the
Buyers. The Company shall have no rights as a third party
beneficiary of any of the provisions of this Article. The use of
the term “agent” or any similar or equivalent term in
connection with the appointment of the Agent hereunder is not
intended to imply any fiduciary or other duties arising under legal
principles governing agency relationships, and such appointment and
all rights and duties of the Agent hereunder shall be ministerial
and administrative in nature.
(b) Rights As a Buyer. The Person
serving as the Agent hereunder shall have the same rights and
powers in its capacity as a Buyer as any other Buyer. Accordingly,
the Agent, in its capacity as a Buyer, may exercise all rights and
powers of a Buyer as though it were not the Agent, and the term
Buyer or Buyers shall, unless otherwise expressly indicated or
unless the context otherwise requires, include the Person serving
as the Agent hereunder in its individual capacity. Such Person and
its Affiliates may lend money to, own securities of, act in any
advisory capacity for and generally engage in any kind of business
with the Company or other Affiliate thereof, all as if such Person
were not the Agent hereunder and without any duty to account
therefor to the Buyers.
(c) Exculpatory Provisions. The
Agent shall not have any duties or obligations except those
expressly set forth herein and in the other Transaction Documents,
which shall be ministerial and administrative in nature. Without
limiting the generality of the foregoing, the Agent:
(i) shall not be
subject to any fiduciary or other implied duties, regardless of
whether a default or an Event of Default (as defined in the Notes)
has occurred and is continuing;
(ii) shall
not have any duty to take any discretionary action or exercise any
discretionary powers, except discretionary rights and powers
expressly contemplated hereby or by the other Transaction Documents
that the Agent is required to exercise as directed in writing by
the Required Note Holders (or such other number or percentage of
the Buyers as shall be expressly provided for herein or in the
other Transaction Documents); provided that, the Agent shall not be
required to take any action that, in its opinion or the opinion of
its counsel, may expose the Agent to liability or that is contrary
to any Transaction Document or applicable law; and
(iii) shall
not, except as expressly set forth herein and in the other
Transaction Documents, have any duty to disclose, and shall not be
liable for the failure to disclose, any information relating to the
Company or any of its Affiliates that is communicated to or
obtained by the Person serving as the Agent or any of its
Affiliates in any capacity.
The
Agent shall not be liable for any action taken or not taken by it
(i) with the consent or at the request of the Required Note Holders
(or such other number or percentage of the Buyers as shall be
necessary, or as the Agent shall believe in good faith shall be
necessary, under the circumstances as provided in the Transaction
Documents) or (ii) in the absence of its own gross negligence or
willful misconduct as determined by a final and non-appealable
judgment of a court of competent jurisdiction.
The
Agent shall not be responsible for or have any duty to ascertain or
inquire into (i) any statement, warranty or representation made in
or in connection with this Agreement or any other Transaction
Document, (ii) the contents of any certificate, report or other
document delivered hereunder or thereunder or in connection
herewith or therewith, (iii) the performance or observance of any
of the covenants, agreements or other terms or conditions set forth
herein or therein or the occurrence of any default or Event of
Default, (iv) the validity, enforceability, effectiveness or
genuineness of this Agreement, any other Transaction Document or
any other agreement, instrument or document or the creation,
perfection or priority of any Lien purported to be created by the
Security Agreement executed and delivered by the Company to the
Agent granting a Lien to secure any of the Obligations, (v) the
value or the sufficiency of any Collateral, or (vi) the
satisfaction of any condition set forth herein.
(d) Reliance By Agent. The Agent
shall be entitled to rely upon, and shall not incur any liability
for relying upon, any notice, request, certificate, consent,
statement, instrument, document or other writing (including any
electronic message, internet or intranet website posting or other
distribution) believed by it to be genuine and to have been signed,
sent or otherwise authenticated by the proper Person. The Agent
also may rely upon any statement made to it orally or by telephone
and believed by it to have been made by the proper Person, and
shall not incur any liability for relying thereon. The Agent may
consult with legal counsel (who may be counsel for the Company),
independent accountants and other experts selected by it, and shall
not be liable for any action taken or not taken by it in accordance
with the advice of any such counsel, accountants or
experts.
12
(e) Resignation of
Agent.
(i) The Agent may at
any time give notice of its resignation to the Buyers and the
Company. Upon receipt of any such notice of resignation, the
Required Note Holders shall have the right to appoint a successor
Agent. If no such successor shall have been so appointed by the
Required Note Holders and shall have accepted such appointment
within thirty (30) days after the retiring Agent gives notice of
its resignation, or by such earlier date as agreed by the Required
Note Holders (the “Agent
Resignation Date”), then the retiring Agent may, but
shall not be obligated to, on behalf of the Buyers, appoint a
successor Agent. Regardless of whether a qualifying Person has
accepted such appointment, such resignation shall nonetheless
become effective in accordance with such notice on the Agent
Resignation Date.
(ii) With
effect from the Agent Resignation Date (i) the retiring Agent shall
be discharged from its duties and obligations hereunder and under
the other Transaction Documents (except that in the case of any
Collateral held by the Agent on behalf of the Buyers under any of
the Transaction Documents, the retiring Agent shall continue to
hold such collateral security until such time as a successor Agent
is appointed) and (ii) except for any indemnity payments owing to
the retiring Agent, all payments, communications and determinations
provided to be made by, to or through the Agent shall instead be
made by or to each Buyer directly, until such time, if any, as the
Required Note Holders appoint a successor Agent as provided for
above in this Section. Upon the acceptance of a successor’s
appointment as Agent hereunder, such successor shall succeed to and
become vested with all of the rights, powers, privileges and duties
of the retiring Agent (except with respect to indemnity payments
owed to the retiring Agent), and the retiring Agent shall be
discharged from all of its duties and obligations hereunder or
under the other Transaction Documents. After the retiring
Agent’s resignation hereunder and under the other Transaction
Documents, the provisions of this Article shall continue in effect
for the benefit of such retiring Agent and its respective
Affiliates in respect of any actions taken or omitted to be taken
by any of them while the retiring Agent was acting as Agent
hereunder.
(f) Indemnification by the Buyers.
The Buyers agree to indemnify the Agent (to the extent the Agent is
not reimbursed by the Company and without limiting the obligations
of the Company hereunder or under any of the other Transaction
Documents), ratably on a pro rata basis based on the principal
amount outstanding under the Notes from and against any and all
liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, costs, expenses or disbursements of any kind or
nature whatsoever which may be imposed on, incurred by, or asserted
against the Agent in any way relating to or arising out of this
Agreement or any other Transaction Document or any action taken or
omitted by the Agent in connection therewith; provided, however, that no Buyer shall
be liable to the extent it is finally judicially determined that
such liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, costs, expenses or disbursements arose primarily
from the Agent’s gross negligence or willful misconduct as
determined by a final and non-appealable judgment of a court of
competent jurisdiction.
(g) Non-Reliance on Agent and Other
Buyers. Each Buyer acknowledges that it has, independently
and without reliance upon the Agent or any other Buyer or any of
their Affiliates and based on such documents and information as it
has deemed appropriate, made its own credit analysis and decision
to enter into this Agreement. Each Buyer also acknowledges that it
will, independently and without reliance upon the Agent or any
other Buyer or any of their Affiliates and based on such documents
and information as it shall from time to time deem appropriate,
continue to make its own decisions in taking or not taking action
under or based upon this Agreement, any other Transaction Document
or any related agreement or any document furnished hereunder or
thereunder. The Agent shall not have any duty or responsibility to
provide any Buyer with any other credit or other information
concerning the affairs, financial condition or business of the
Company that may come into the possession of the
Agent.
(h) Collateral Matters. The Buyers
irrevocably authorize the Agent, at its option and in its
discretion to release any Lien on any property granted to or held
by the Agent under any Transaction Document (i) upon payment in
full of all Obligations (other than contingent indemnification
obligations), (ii) that is sold or otherwise disposed of or to be
sold or otherwise disposed of as part of or in connection with any
sale or other disposition permitted hereunder or under any other
Transaction Document, or (iii) if approved, authorized or ratified
in writing by the Required Note Holders.
Upon
request by the Agent at any time, the Required Note Holders shall
confirm in writing the Agent’s authority to release or
subordinate its interest in particular types or items of
property.
10. MISCELLANEOUS.
(a) Governing Law; Jurisdiction; Jury
Trial. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed
by the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule
(whether of the State of New York or any other jurisdictions) that
would cause the application of the laws of any jurisdictions other
than the State of New York. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts
sitting in The City of New York, Borough of Manhattan, for the
adjudication of any dispute hereunder or in connection herewith or
with any transaction contemplated hereby or discussed herein, and
hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or
proceeding is brought in an inconvenient forum or that the venue of
such suit, action or proceeding is improper. Each party hereby
irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by
mailing a copy thereof to such party at the address for such
notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR
ANY TRANSACTION CONTEMPLATED HEREBY.
13
(b) Counterparts. This Agreement
may be executed in two or more identical counterparts, all of which
shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and
delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the
signatory thereto with the same force and effect as if the
signature were an original, not a facsimile signature.
(c) Construction. The headings of
this Agreement are for convenience of reference and shall not form
part of, or affect the interpretation of, this Agreement. Unless
the context clearly indicates otherwise, each pronoun herein shall
be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,”
“includes,” “include” and words of like
import shall be construed broadly as if followed by the words
“without limitation.” The terms “herein,”
“hereunder,” “hereof” and words of like
import refer to this entire Agreement instead of just the provision
in which they are found. As used herein, “Business Day” means any day other
than Saturday, Sunday or other day on which commercial banks in The
City of New York are authorized or required by law to remain
closed.
(d) Severability; Maximum Payment
Amounts. If any provision of this Agreement is prohibited by
law or otherwise determined to be invalid or unenforceable by a
court of competent jurisdiction, the provision that would otherwise
be prohibited, invalid or unenforceable shall be deemed amended to
apply to the broadest extent that it would be valid and
enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions
of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original
intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the
provision(s) in question does not substantially impair the
respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be
conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable
provision(s) with a valid provision(s), the effect of which comes
as close as possible to that of the prohibited, invalid or
unenforceable provision(s). Notwithstanding anything to the
contrary contained in this Agreement, or any other Transaction
Document (and without implication that the following is required or
applicable), it is the intention of the parties that in no event
shall amounts and value paid by the Company and/or its Subsidiaries
(as the case may be), or payable to or received by any of the
Buyers, under the Transaction Documents (including any amounts that
would be characterized as “interest” under applicable
law) exceed amounts permitted under any applicable law.
Accordingly, if any obligation to pay, payment made to any Buyer,
or collection by any Buyer pursuant the Transaction Documents is
finally judicially determined to be contrary to any such applicable
law, such obligation to pay, payment or collection shall be deemed
to have been made by mutual mistake of such Buyer, the Company and
its Subsidiaries and such amount shall be deemed to have been
adjusted with retroactive effect to the maximum amount or rate of
interest, as the case may be, as would not be so prohibited by the
applicable law.
(e) Entire Agreement; Amendments.
This Agreement and the other Transaction Documents supersede all
other prior oral or written agreements between the Buyers, the
Company, their affiliates and Persons acting on their behalf with
respect to the matters discussed herein, and this Agreement, the
other Transaction Documents and the instruments referenced herein
and therein contain the entire understanding of the parties with
respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor
any Buyer makes any representation, warranty, covenant or
undertaking with respect to such matters. Provisions of this
Agreement may be amended and the observance thereof may be waived
(either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of
the Company and the holders of at least a majority of the aggregate
principal amount of the Notes (the “Required Note Holders”) and the
holders of at least a majority of the aggregate number of Warrant
Shares issued or issuable under the Warrants (the
“Required Warrant
Holders”). Any amendment or waiver effected in
accordance with this Section 10(e) shall be binding upon
each Buyer and holder of Securities and the Company. No such
amendment shall be effective to the extent that it applies to less
than all of the Buyers or holders of Securities. No consideration
shall be offered or paid to any Person to amend or consent to a
waiver or modification of any provision of any of the Transaction
Documents unless the same consideration also is offered to all of
the parties to the Transaction Documents, holders of Notes or
holders of the Warrants, as the case may be. Without limiting the
foregoing, the Company confirms that, except as set forth in this
Agreement, no Buyer has made any commitment or promise or has any
other obligation to provide any financing to the Company or
otherwise. As a material inducement for each Buyer to enter into
this Agreement, the Company expressly acknowledges and agrees that
no due diligence or other investigation or inquiry conducted by a
Buyer, any of its advisors or any of its representatives shall
affect such Buyer’s right to rely on, or shall modify or
qualify in any manner or be an exception to any of, the
Company’s representations and warranties contained in this
Agreement or any other Transaction Document.
14
(f) Notices. Any notices, consents,
waivers or other communications required or permitted to be given
under the terms of this Agreement must be in writing and will be
deemed to have been delivered: (i) upon receipt, when delivered
personally; (ii) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically
generated and kept on file by the sending party) or by electronic
mail; or (iii) one Business Day after deposit with an overnight
courier service, in each case properly addressed to the party to
receive the same. The addresses, facsimile numbers and e-mail
addresses for such communications shall be:
If to
the Company:
000
Xxxxx Xxxxx Xxxxxx, Xxxxx 0000
Xxxxxx,
XX 00000
Telephone:
|
000-000-0000
|
Attention:
|
Chief Executive
Officer
|
With a
copy (for informational purposes only) to:
Sichenzia Xxxx
Xxxxxxx LLP
0000
Xxxxxx xx xxx Xxxxxxxx, 00xx Xxxxx
Xxx
Xxxx, XX 00000]
Telephone:
|
(000)
000-0000
|
Facsimile:
|
(000)
000-0000
|
Attention:
|
Xxxxxx X. Xxxxxx,
Esq.
|
E-mail:
|
xxxxxxxx@xxx.xxx
|
If to a
Buyer, to its address, facsimile number and e-mail address set
forth on the Schedule of Buyers, with copies (for informational
purposes only) to such Buyer’s representatives, if any, as
set forth on the Schedule of Buyers;
or to
such other address, facsimile number and/or e-mail address and/or
to the attention of such other Person as the recipient party has
specified by written notice given to each other party five (5) days
prior to the effectiveness of such change. Written confirmation of
receipt (A) given by the recipient of such notice, consent, waiver
or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine or e-mail
containing the time, date, recipient facsimile number and an image
of the first page of such transmission or (C) provided by an
overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from an overnight courier
service in accordance with clause (i), (ii) or (iii) above,
respectively.
(g) Successors and Assigns. This
Agreement shall be binding upon and inure to the benefit of the
parties and their respective successors and assigns, including any
purchasers of the Notes or the Warrants. The Company shall not
assign this Agreement or any rights or obligations hereunder
without the prior written consent of the Required Note Holders,
including by way of a Fundamental Transaction (unless the Company
is in compliance with the applicable provisions governing
Fundamental Transactions set forth in the Notes and the Warrants).
A Buyer may assign some or all of its rights hereunder in
connection with any transfer of any of its Securities without the
consent of the Company, in which event such assignee shall be
deemed to be a Buyer hereunder with respect to such assigned
rights.
(h) Third Party Beneficiaries. This
Agreement is intended for the benefit of the parties hereto and
their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any
other Person, except that each Indemnitee shall have the right to
enforce the obligations of the Company with respect to Section 10(k).
(i) Survival. The representations,
warranties, agreements and covenants shall survive the Closing.
Each Buyer shall be responsible only for its own representations,
warranties, agreements and covenants hereunder.
(j) Further Assurances. Each party
shall do and perform, or cause to be done and performed, all such
further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as any
other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation
of the transactions contemplated hereby.
15
(k) Indemnification. In
consideration of each Buyer’s execution and delivery of the
Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company’s other obligations under
the Transaction Documents, the Company shall defend, protect,
indemnify and hold harmless each Buyer and each other holder of the
Securities and all of their stockholders, partners, members,
officers, directors, employees and direct or indirect investors and
any of the foregoing Persons’ agents or other representatives
(including those retained in connection with the transactions
contemplated by this Agreement) (collectively, the
“Indemnitees”)
from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages,
and expenses in connection therewith (irrespective of whether any
such Indemnitee is a party to the action for which indemnification
hereunder is sought), and including reasonable attorneys’
fees and disbursements (the “Indemnified Liabilities”),
incurred by any Indemnitee as a result of, or arising out of, or
relating to (a) any misrepresentation or breach of any
representation or warranty made by the Company in the Transaction
Documents or any other certificate, instrument or document
contemplated hereby or thereby, (b) any breach of any covenant,
agreement or obligation of the Company contained in the Transaction
Documents or any other certificate, instrument or document
contemplated hereby or thereby or (c) any cause of action, suit or
claim brought or made against such Indemnitee by a third party
(including for these purposes a derivative action brought on behalf
of the Company) and arising out of or resulting from (i) the
execution, delivery, performance or enforcement of the Transaction
Documents or any other certificate, instrument or document
contemplated hereby or thereby, (ii) any transaction financed or to
be financed in whole or in part, directly or indirectly, with the
proceeds of the issuance of the Securities, (iii) any disclosure
made by such Buyer pursuant to Section 4(e), or (iv) the status of
such Buyer or holder of the Securities as an investor in the
Company pursuant to the transactions contemplated by the
Transaction Documents. To the extent that the foregoing undertaking
by the Company may be unenforceable for any reason, the Company
shall make the maximum contribution to the payment and satisfaction
of each of the Indemnified Liabilities that is permissible under
applicable law.
(l) No Strict Construction. The
language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any party. No
specific representation or warranty shall limit the generality or
applicability of a more general representation or warranty. Each
and every reference to share prices, shares of Common Stock and any
other numbers in this Agreement that relate to the Common Stock
shall be automatically adjusted for any stock splits, stock
dividends, stock combinations, recapitalizations or other similar
transactions that occur with respect to the Common Stock after the
date of this Agreement.
(m) Remedies. Each Buyer and each
holder of the Securities shall have all rights and remedies set
forth in the Transaction Documents and all rights and remedies
which such holders have been granted at any time under any other
agreement or contract and all of the rights which such holders have
under any law. Any Person having any rights under any provision of
this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security), to recover
damages by reason of any breach of any provision of this Agreement
and to exercise all other rights granted by law. Furthermore, the
Company recognizes that in the event that it fails to perform,
observe, or discharge any or all of its obligations under the
Transaction Documents, any remedy at law may prove to be inadequate
relief to the Buyers. The Company therefore agrees that the Buyers
shall be entitled to seek temporary and permanent injunctive relief
in any such case without the necessity of proving actual damages
and without posting a bond or other security. The remedies provided
in this Agreement and the other Transaction Documents shall be
cumulative and in addition to all other remedies available under
this Agreement and the other Transaction Documents, at law or in
equity (including a decree of specific performance and/or other
injunctive relief).
(n) Rescission and Withdrawal
Right. Notwithstanding anything to the contrary contained in
(and without limiting any similar provisions of) the Transaction
Documents, whenever any Buyer exercises a right, election, demand
or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein
provided, then such Buyer may rescind or withdraw, in its sole
discretion from time to time upon written notice to the Company,
any relevant notice, demand or election in whole or in part without
prejudice to its future actions and rights.
(o) Payment Set Aside. To the
extent that the Company makes a payment or payments to the Buyers
hereunder or pursuant to any of the other Transaction Documents or
the Buyers enforce or exercise their rights hereunder or
thereunder, and such payment or payments or the proceeds of such
enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside,
recovered from, disgorged by or are required to be refunded, repaid
or otherwise restored to the Company, a trustee, receiver or any
other Person under any law (including any bankruptcy law, foreign,
state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part
thereof originally intended to be satisfied shall be revived and
continued in full force and effect as if such payment had not been
made or such enforcement or setoff had not occurred.
(p) Independent Nature of Buyers’
Obligations and Rights. The obligations of each Buyer under
any Transaction Document are several and not joint with the
obligations of any other Buyer, and no Buyer shall be responsible
in any way for the performance of the obligations of any other
Buyer under any Transaction Document. Nothing contained herein or
in any other Transaction Document, and no action taken by any Buyer
pursuant hereto or thereto, shall be deemed to constitute the
Buyers as, and the Company acknowledges that the Buyers do not so
constitute, a partnership, an association, a joint venture or any
other kind of entity, or create a presumption that the Buyers are
in any way acting in concert or as a group, and the Company shall
not assert any such claim with respect to such obligations or the
transactions contemplated by the Transaction Documents and the
Company acknowledges that the Buyers are not acting in concert or
as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. The Company acknowledges
and each Buyer confirms that it has independently participated in
the negotiation of the transaction contemplated hereby with the
advice of its own counsel and advisors. Each Buyer shall be
entitled to independently protect and enforce its rights, including
the rights arising out of this Agreement or out of any other
Transaction Documents, and it shall not be necessary for any other
Buyer to be joined as an additional party in any proceeding for
such purpose.
[Signature
Page Follows]
16
IN
WITNESS WHEREOF, each Buyer and the Company have caused their
respective signature page to this Securities Purchase Agreement to
be duly executed as of the date first written above.
|
COMPANY:
|
|
|
|
|
|
||
|
|
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
Title:
|
|
|
|
17
IN
WITNESS WHEREOF, each Buyer and the Company have caused their
respective signature page to this Securities Purchase Agreement to
be duly executed as of the date first written above.
|
BUYERS:
|
|
|
||
|
S7 Finance B.V.
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
Title:
|
|
|
|
|
|
|
|
|
Xxxx Xxxxxxxx-Xxxxx
|
18